Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 23:13:941788.
doi: 10.3389/fneur.2022.941788. eCollection 2022.

Longitudinal investigation of the factor structure of the Parkinson's disease activities of daily living, interference and dependence instrument

Cristian Sirbu  1   2   3 , Brian K Saxby  1 , Cynthia W McNamara  1 , Linda S Deal  4
Affiliations

Longitudinal investigation of the factor structure of the Parkinson's disease activities of daily living, interference and dependence instrument

Cristian Sirbu et al. Front Neurol. .

Abstract

The Parkinson's Disease Activities of Daily Living, Interference, and Dependence Instrument© (PD-AID) is a patient-reported outcome (PRO) instrument, recently developed to assess the clinical benefit of Parkinson's Disease (PD) treatment. The PD-AID consists of morning and evening assessments, administered daily. To benefit from the full set of the repeated observations over time, analytic approaches that account for both within- and between-individual variability are required. The current study aimed to employ the advantages of exploratory Multilevel Factor Analysis (MFA) on data collected from 93 participants with moderate to advanced PD, currently using and responding to Levodopa (L-Dopa), who completed the PD-AID twice daily as part of a prospective, non-intervention, observational study for ~28 days. Average daily completion rates were comparable for the Morning and the Evening PD-AID (78% and 74%, respectively). The intraclass correlation coefficients for the Morning and Evening PD-AID items were in the range of 0.70-0.90, with an average of 0.81 for the Morning PD-AID items and 0.83 for the Evening PD-AID items, suggesting that most variability (81%-83%) in responses was due to between-individual variability. For the Morning PD-AID, one factor (including nine out of 10 Morning PD-AID items) emerged at the between-individual level and four factors (core physical actions, basic self-care activities, feeding, and interference & dependence) at the within-individual level. For the Evening PD-AID, there were four between-individual factors (basic activities of daily living ADLs, life interference, impact on planning, and emotional consequences) and five within-individual factors (basic ADLs, toileting, life interference, medication planning, and emotional impact). The factors had high reliability.

Keywords: Multilevel Factor Analysis; PD-AID; Parkinson's disease; activities of daily living; longitudinal validation; patient reported outcomes (PRO).

PubMed Disclaimer

Conflict of interest statement

CS, BS, and CM are employees of Cronos Clinical Consulting Services, Inc., the entity responsible for licensing of the PD-AID, including commercial license fees for use in industry-sponsored clinical trials. LD is the lead developer of the PD-AID and an employee of Pfizer, Inc., the funding source for the research. No authors receive any licensing fees from the PD-AID.

Figures

Figure 1
Figure 1
Within-individual and between-individuals factors standardized loadings and correlations for the Morning PD-AID.
Figure 2
Figure 2
Within-individual and between-individuals factors standardized loadings and correlations for the Evening PD-AID.
See this image and copyright information in PMC

References

    1. Williams DR, Litvan I. Parkinsonian syndromes. Continuum. (2013) 19:1189–212. 10.1212/01.CON.0000436152.24038.e0 - DOI - PMC - PubMed
    1. Dorsey ER, Constantinescu JP, Thompson KM, Biglan RG, Holloway K, Kieburtz FJ, et al. . Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. (2007) 68:384–6. 10.1212/01.wnl.0000247740.47667.03 - DOI - PubMed
    1. Thanvi B, Lo N, Robinson T. Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment. Postgrad Med J. (2007) 83:384–8. 10.1136/pgmj.2006.054759 - DOI - PMC - PubMed
    1. Rizos A, Martinez-Martin P, Odin P, Antonini A, Kessel B, Klemencic Kozul T, et al. . Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study. Parkinsonism Relat Disord. (2014) 20:1231–5. 10.1016/j.parkreldis.2014.09.013 - DOI - PubMed
    1. Deal LS, Flood E, Myers DE, Devine J, Gray DL. The Parkinson's disease activities of daily living, interference, and dependence instrument. Mov Disord Clin Pract. (2019) 6:678–86. 10.1002/mdc3.12833 - DOI - PMC - PubMed

LinkOut - more resources